- 14 March
-
At the end of the last year, Novouralsk-based Medsintez Plant turned 20 years old. Alexander Petrov, Chairman of the plant's Board of Directors, told Regions of Russia about the impressive successes that the company has achieved over the years and its ambitious plans for the future.
- 22 January
-
In 2023, the Medsintez Plant, in collaboration with the Promomed Group of Companies, launched the production of a full cycle of hypoglycemic drugs Enligria (liraglutide) and Quincenta (semaglutide) used in treating type II diabetes mellitus, including in patients with obesity and overweight or cardiovascular disease. The preparations are available in the most convenient and familiar for patients dosage form – a disposable prefilled injection and have already been supplied to pharmacies.
- 13 December
-
Medsintez Plant LLC presented the latest biotechnological developments of pharmaceuticals at the largest international scientific and practical forum in the field of medicine and health care Russian Health Care Week — 2023 held from December 4 to December 8 in Moscow. The main purpose of the Forum is to facilitate the implementation of the national projects “Healthcare” and “Demography”, “Tourism and Hospitality Industry”, the federal project “Development of Medical Services Export”, as well as summarizing the results of the Year of Science and Technology in Medicine.
- 04 October
-
On September 27, as part of the business program of the GMP conference with international participation, Alexander Petrov, Chairman of the Board of Directors of Medsintez Plant LLC, took part in a Plenary Session on the issues of regulating the circulation of medicines in Russia and the EAEU, developing import independence, and increasing export potential. The session was attended by representatives of the Ministry of Industry and Trade of the Russian Federation, the Minister of Health of the Republic of Nicaragua, the WHO Representative in Russia, a Representative of the Serbian Ministry of Health and other Russian and foreign experts. Mr. Petrov spoke about the problems that Russian pharmaceutical companies face when entering international markets and suggested possible solutions.
- Home
- Cluster members
- Medica Group LLC
Medica Group LLC
Medica Group LLC is engaged in the localization of a joint Russian-Chinese project for the production of automatic microbiology analyzers on the territory of priority development in Novouralsk. The corresponding document was signed in the management company of the territory of advanced social and economic development (TASED) Atom- TOR. The project of localization of production in Russia was our response to the imposition of sanctions and threats of vital product lack. This project for the production of analyzers and culture vials gives us independence from foreign supplies.
Areas of company activities:
- Laboratory consumables;
- Modern solutions for microbiological laboratories;
- Medical equipment;
Clinical microbiology is an important link in the study of pathogenic features, pathogen diagnosis, rational use of antimicrobials and monitoring of nosocomial infection.
Sepsis is a fatal disease. About 30% of patients are misdiagnosed. This is due to the fact that current detection methods have low specificity and are slow. It takes days to get results, leading doctors to prescribe ineffective antibiotics, which in turn leads to the spread of antibiotic-resistant strains and increased deaths caused by blood infections. Every hour of delay in the use of effective antibiotics reduces survival by 7.6%. The introduction of innovative technologies in microbiological laboratories allows raising diagnostics to a new level, reducing the time for issuing results to 18-24 hours.
Automatic analyzers using advanced technology:
- YUNONA®LABSTAR model for testing the sterility of blood cultures and other biological fluids;
- Vials for blood cultures;
- YUNONA® HK model for identification of microorganisms and determination of sensitivity to antibiotics;
- Reagent kits for identification and sensitivity to antibiotics;
Automation of microbiological laboratories is an increase in the efficiency that directs the diagnosis, treatment and prevention of infectious diseases to obtain a quick and accurate diagnosis.
Medica Group of companies
Phone: +7 (343) 270-75-17
E-mail: medica.group@mail.ru
